Download PDF
Thromb Haemost 1997; 77(03): 600
DOI: 10.1055/s-0038-1656011
Letter to the Editor
Schattauer GmbH Stuttgart

Does the Q506 Mutation of Factor V Contribute to Thrombotic Events in the Nephrotic Syndrome?

A Magdelaine
1   Service d’Hématologie biologique, Hôpital Tenon, Paris, France
,
K Akposso
2   Service de Nephrologie A, Hôpital Tenon, Paris, France
,
E Verdy
1   Service d’Hématologie biologique, Hôpital Tenon, Paris, France
,
V Noc
3   Service de Néphrologie B, Hôpital Tenon, Paris, France
,
M N Peraldi
2   Service de Nephrologie A, Hôpital Tenon, Paris, France
,
P Ronco
3   Service de Néphrologie B, Hôpital Tenon, Paris, France
,
E Rondeau
2   Service de Nephrologie A, Hôpital Tenon, Paris, France
› Author Affiliations
Further Information

Publication History

Received 05 September 1996

Accepted after revision 14 November 1996

Publication Date:
11 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Andrassy K, Ritz E, Bommer J. Hypercoagulability in the nephrotic syndrome. Klin Wschr 1980; 58: 1029-1036
    CrossrefPubMedGoogle Scholar
  • 2 Cameroun JS. Clinical consequences of the nephrotic syndrome. In: Oxford text book of clinical nephrology. Cameroun S, Grunfeld JP, Kerr D, Ritz E. eds. Oxford University Press; 1992. 01. 0276-0296
    Google Scholar
  • 3 Vigano G, Remuzzi G. Coagulation abnormalities of patients with chronic renal failure. In: Oxford text book of clinical nephrology. Cameroun S, Grunfeld JP, Kerr D, Ritz E. eds. Oxford University Press; 1992. 02. 1361-1364
    Google Scholar
  • 4 Chen TY, Huang CC, Tsao CJ. Hemostatic molecular markers in nephrotic syndrome. Am J Hematol 1993; 44: 0276-0279
    CrossrefPubMedGoogle Scholar
  • 5 Dahlbӓck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C:prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
    CrossrefPubMedGoogle Scholar
  • 6 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 0006-0007
    PubMedGoogle Scholar
  • 7 Dahlbӓck B. Inherited resistance to activated protein C:A single point mutation in the gene for factor V as a major risk factor for venous thrombosis. In: Hypercoagulable states:fundamental aspects, acquired disorders, and congenital thrombophilia. Seghatchian MJ, Samama M, Hecker SP. eds. CRC Press; 1996: 0365-0373
    Google Scholar
  • 8 Rees C, Cox M, Clegg J. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
    CrossrefPubMedGoogle Scholar
  • 9 Petaja J, Jalanko H, Holmberg C, Kinnunen S, Syrjala M. Resistance to activated protein C as an underlying cause of recurrent venous thrombosis during relapsing nephrotic syndrome. J Pediatrics 1995; 127: 0103-0105
    CrossrefPubMedGoogle Scholar